• Shimadzu’s joint research with Tohoku University demonstrated cyclo-octasulfur in mammalian cells and tissues; results were published in Science on September 24, 2026.
• Breast cancer tissue showed higher cyclo-octasulfur levels than normal tissue; patients’ exhaled breath also contained increased supersulfide molecules.
• The findings could support preventive and therapeutic approaches targeting supersulfide metabolism for cancer, inflammatory conditions and age-related diseases.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Shimadzu Corporation published the original content used to generate this news brief on October 26, 2026, and is solely responsible for the information contained therein.